Intellia Therapeutics, Inc. (NTLA) Backed by H.C. Wainwright for 237% Upside Potential

finance.yahoo.com/news/intellia-therapeutics-inc-ntla-backed-173212108.html

In This Article:
Intellia Therapeutics, Inc. (NASDAQ:NTLA) is among the best NASDAQ stocks under $50 to buy. Analysts at H.C. Wainwright have reaffirmed a Buy rating on Intellia Therapeutics, Inc. (NASDAQ:NTLA) while maintaining a price target of $30.00. This whopping 237% upside from…

This story appeared on finance.yahoo.com, 2025-06-17 17:32:12.
The Entire Business World on a Single Page. Free to Use →